15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 15 firms covering CME Group Inc, 8 rate it Buy or better, 5 sit at Hold, and 2 rate it Sell or worse, a moderate buy consensus. Targets span $230.00 to $330.00, a moderate spread. The average target of $288.85 sits 11% above the current $260.14. Sentiment has cooled somewhat, with Sell ratings rising from 1 to 2 over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.97 next quarter toward $12.94 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS15 ratings
Moderate Buy
Strong Buy00%
Buy853%
Hold533%
Sell213%
Strong Sell00%
Based on 15 analysts giving stock ratings to CME Group Inc.
As of Jul, 8 of 15 firms rate CME a Buy (5 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
CME EPS & revenue forecast
EPS · NEXT QUARTER
$2.97
Range $2.75 – $3.21 · 13 analysts · +7% YoY
Next period, 13 analysts expect CME Group Inc to earn $2.97 a share (range $2.75 – $3.21), versus $2.77 a year earlier. Full-year consensus is $12.27, growing to $12.94 the year after.
REVENUE · NEXT QUARTER
$1.7B
Range $1.6B – $1.9B · 13 analysts · +6% YoY
Revenue is expected to reach $1.7B (range $1.6B – $1.9B), +5.6% year-over-year. Full-year consensus is $7.0B, rising to $7.4B next year.
Top analysts covering CME Group Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CME.
#1
Patrick Moley
Piper Sandler · Rank #92
Buy
$295.00+13.4% to target
Overall win rate
42%
+ Follow
#2
Benjamin Budish
Barclays · Rank #101
Hold
$270.00+3.8% to target
Overall win rate
48%
+ Follow
#3
Michael Cyprys
Morgan Stanley · Rank #253
Buy
$330.00+26.9% to target
Overall win rate
39%
+ Follow
#4
Alex Kramm
UBS
Hold
$260.00-0.1% to target
Coverage
—
+ Follow
#5
Ashish Sabadra
RBC Capital
Hold
$302.00+16.1% to target
Coverage
—
+ Follow
CME stock forecast FAQ
What is CME's average 12-month price target?+
The 13 analysts with a live target average $288.85 for CME Group Inc over the next 12 months, ranging from a $330.00 high to a $230.00 low.
Is CME stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 15 analyst ratings, 8 are Buy or Strong Buy, 5 are Hold, and 2 are Sell or Strong Sell.
What are the highest and lowest price targets for CME?+
The Street-high target is $330.00 (Morgan Stanley), and the Street-low is $230.00 (B of A Securities). The average of all 13 active targets is $288.85.
How many Wall Street analysts cover CME?+
15 analysts have an active rating on CME Group Inc, and 13 firms carry a live 12-month price target.
Who is the most accurate analyst covering CME?+
Among analysts who currently cover CME, Patrick Moley of Piper Sandler has the strongest overall Quantellect track record (Rank #92). Their current call is Buy with a $295.00 target.
What is CME Group Inc's projected EPS for next quarter?+
The consensus estimate is $2.97 per share (range $2.75 – $3.21) across 13 analysts. Full-year EPS is projected at $12.27, rising to $12.94 the following year.
How much revenue is CME Group Inc expected to report next quarter?+
Consensus revenue is $1.7B (range $1.6B – $1.9B). Full-year revenue is projected at $7.0B, growing to $7.4B next year.
Have analysts been upgrading or downgrading CME lately?+
As of Jul, 8 of 15 firms rate CME a Buy (5 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CME calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
